Kardigan
PrivateLast Round
Series B
Oct 14, 2025
Total Funding Raised
$554M
Momentum Score
50 /100
Company Overview
Kardigan is a biopharmaceutical company focused on modernizing cardiovascular drug development. Founded in 2023 by former executives of MyoKardia, the company launched in January 2025 with a $300 million Series A financing. Kardigan aims to develop multiple targeted treatments in parallel, moving beyond symptom management to functional cures for cardiovascular diseases. The company's R&D platform utilizes a proprietary set of cardiac-specific tools and a portfolio of late-stage clinical candidates to match disease drivers with treatment responders, aiming to streamline clinical trials. Kardigan has offices in South San Francisco, California, and Princeton, New Jersey.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kardigan Comps
Public and private peers based on sector, stage, and business model.
Kardigan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 14, 2025 | ||||
| Series A | Jan 10, 2025 |
Key People
Founding team and executive leadership
Kardigan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| HRTG Partners | Series B, Series A |
| ARCH Venture Partners | Series B, Series A |
| Fidelity Management & Research Company | Series B |
| ARCH Venture Partners | Series B, Series A |
| T. Rowe Price | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 23% QoQ, from 144 to 177 employees.
- Apr 25, 2026
Grew 18% QoQ, from 141 to 167 employees.
Kardigan Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kardigan's valuation, stock price, and market status.
